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ABSTRACT
Renal perfusion provides the driving pressure for glomerular
ﬁltration and delivers the oxygen and nutrients to fuel solute
reabsorption. Renal ischaemia is a major mechanism in acute
kidney injury and may promote the progression of chronic
kidney disease. Thus, quantifying renal tissue perfusion is
critically important for both clinicians and physiologists.
Current reference techniques for assessing renal tissue perfu-
sion have signiﬁcant limitations. Arterial spin labelling (ASL)
is a magnetic resonance imaging (MRI) technique that
uses magnetic labelling of water in arterial blood as an
endogenous tracer to generate maps of absolute regional per-
fusion without requiring exogenous contrast. The technique
holds enormous potential for clinical use but remains
restricted to research settings. This statement paper from the
PARENCHIMA network brieﬂy outlines the ASL technique
and reviews renal perfusion data in 53 studies published in
English through January 2018. Renal perfusion by ASL has
been validated against reference methods and has good
reproducibility. Renal perfusion by ASL reduces with age and
excretory function. Technical advancements mean that a
renal ASL study can acquire a whole kidney perfusion
measurement in less than 5–10min. The short acquisition
time permits combination with other MRI techniques that
might inform drug mechanisms and renal physiology. The
ﬂexibility of renal ASL has yielded several variants of the tech-
nique, but there are limited data comparing these approaches.
We make recommendations for acquiring and reporting renal
ASL data and outline the knowledge gaps that future research
should address.
Keywords: arterial spin labelling, kidney, magnetic resonance
imaging, renal perfusion, systematic review
INTRODUCTION
There is a complex interaction between renal perfusion, renal
oxygen delivery, renal oxygen consumption and glomerular fil-
tration. Interested readers are referred to detailed reviews [1, 2].
The kidney is unique because>80% of its oxygen consumption
is used to power tubular sodium reabsorption. Consequently,
the oxygen consumption of the kidney varies with glomerular
filtration rate (GFR), and thus renal blood flow. In all other
organs of the body, the direction of causation is reversed, with
changes in tissue metabolic activity leading to changes in vascu-
lar tone, and thus perfusion. Another unique aspect of the renal
circulation is the presence of separate cortical and medullary
circulations. All blood flow to the kidney (25% of cardiac out-
put at rest or 1200mL/min or 400mL/100 g/min in a 70 kg
adult with a 300 g kidney) passes through the glomeruli of the
renal cortices. The renal medullary circulation (the vasa recta)
arises from the efferent arterioles of a subpopulation of glomer-
uli at the corticomedullary junction (the juxtamedullary glo-
meruli). Thus only10% of renal blood flow perfuses the renal
medulla, with evidence that cortical and medullary circulations
are independently regulated [3]. There is evolving evidence that
renal tissue ischaemia and associated hypoxia are critical factors
in the initiation and progression of both acute kidney injury
(AKI) and chronic kidney disease (CKD), irrespective of the un-
derlying aetiology [4]. Thus to understand the physiological
regulation of renal perfusion and the role of its dysregulation in
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kidney disease and injury, we require methods that allow quan-
tification of renal perfusion both at the whole organ level and at
the local tissue level. Traditional reference techniques for assess-
ing renal tissue perfusion in animals and humans have signifi-
cant limitations with no gold-standard technique available [5].
Arterial spin labelling (ASL) is a magnetic resonance imaging
(MRI) technique that uses the magnetic labelling of water in ar-
terial blood as an endogenous tracer to quantify regional perfu-
sion. The purpose of this review is to outline the ASL technique
and summarize all human non-cancer studies performed since
the technique was first described. Current gaps in knowledge
are identified and recommendations for future studies are
made.
MATERIALS AND METHODS
A literature search was conducted in PubMed, Ovid MEDLINE
and Ovid Embase on 4 January 2018. The search strategy is out-
lined in detail in the Supplementary data. In brief, it comprised
the terms arterial spin label, kidney, renal circulation, renal
blood flow and renal perfusion. Conference abstracts, animal
studies and human studies of renal cancer were excluded.
Studies not published in English were excluded. Study charac-
teristics were abstracted and cross-validated by multiple
reviewers.
RESULTS
Study characteristics and important MRI parameters are sum-
marized in Supplementary data, Table S1. Studies were gener-
ally small (mean 256 23 participants, range 4–98 participants)
and predominantly described healthy volunteers. Hydration
status was rarely reported. The time of day at which the scan
was collected was described in only 7 of 53 studies, which might
be pertinent due to circadian variations in renal haemodynam-
ics. Renal cortical perfusion by ASL ranged from 139 to
427mL/100 g/min in healthy volunteers and from 83 to
412mL/100 g/min in a broad range of patient groups. The re-
producibility of renal perfusion by ASL was reported in 17 of
53 studies. Several papers reported renal ASL perfusion values
under physiological challenges. Renal ASL perfusion values
were generally lower in CKD patients compared with healthy
subjects and were correlated with estimated GFR (eGFR).
BASIC PRINCIPLES OF ASL
ASL uses blood water as a freely diffusible tracer to quantify re-
nal perfusion in physiological units of mL/100 g/min. The basic
ASL experiment collects two image types, referred to as the ‘la-
bel’ (or tag) and ‘control’ images. The label is applied using
radiofrequency (RF) pulses to alter the longitudinal magnetiza-
tion of protons in the arterial blood water before it enters the
imaging plane, and an image is collected after a delay time. The
control image is acquired at the same delay time without label-
ling the arterial blood protons. Provided that the inverted mag-
netization of the inflowing blood is the only difference between
the control and label images, a simple subtraction of the label
from the control image yields a perfusion-weighted image in
which signal intensity is proportional to perfusion (Figure 1).
The signal in each voxel of the perfusion-weighted image is
entered into a kinetic model to quantify the perfusion-weighted
signal and thus generate a quantitative perfusion map
(Supplementary data). ASL schemes can be classified into three
major groups: pulsed ASL (PASL), continuous ASL (CASL) and
pseudo-continuous ASL (pCASL) schemes, with PASL and
pCASL being the most widely used schemes for renal ASL. The
flow-sensitive alternating inversion recovery (FAIR) variant is
the PASL scheme most widely used in renal imaging
(Supplementary data, Table S1). It uses an RF pulse centred on
the imaging plane to invert a large volume of blood (label) and
an adiabatic RF pulse to invert a spatially selective region (con-
trol). In CASL, a single long-duration RF pulse is applied to in-
vert the arterial magnetization as blood flows through the
labelling plane while a gradient is applied in the direction of ar-
terial flow. In pCASL, a long series of short RF pulses are used
to mimic the action of CASL but limit the energy deposition
(specific absorption rate). pCASL is more compatible with
modern MRI scanners, thus making it more feasible for clinical
use (Figure 1) than original CASL implementations. In all cases,
the label decays with the longitudinal relaxation time (T1) for
tissue or blood, which is a variable dependent on magnetic field
strength. Each label or control image is acquired after a delay
time, with the image readout taking one of several schemes
(Supplementary data). ASL techniques have intrinsically
low signal:noise ratio, with a typical renal cortex perfusion-
weighted signal intensity of 5% of the control image signal. To
improve signal:noise ratio, multiple ASL control-label pairs are
collected and the perfusion-weighted difference signals are av-
eraged. Renal ASL is inherently susceptible to respiratory-
inducedmotion of the kidney between label and control images,
although averaging acts to suppress to some extent such
motion-related artefacts. Limiting motion artefacts during im-
age acquisition is a critical issue in renal ASL [6]. Several alter-
native strategies have been employed to limit the effects of
motion (Supplementary data).
VALIDATION OF RENAL ASL TO MEASURE
RENAL PERFUSION
Techniques for assessing renal tissue perfusion in animals and
humans have significant limitations, with no available gold-
standard technique. In animal experiments, microspheres can
be used. However, due to the phenomenon of plasma skim-
ming, these methods are inaccurate in the kidney [5].
Furthermore, as microspheres are trapped in the pre-
glomerular and glomerular circulations, they are unsuitable for
medullary perfusion. Analyses of microsphere concentration
must be done post-mortem, so this method is unsuitable for use
in humans. The plasma clearance of para-aminohippurate
measures effective renal blood flow in humans but is limited by
its incomplete and variable renal extraction, making it a ‘bronze
standard’ at best [5]. It also provides no information about the
relative perfusion of the renal cortex andmedulla. Renal scintig-
raphy lacks spatial resolution and uses ionizing radiation, limit-
ing repeatability. Computed tomography also uses ionizing
radiation [7] and requires contrast agents that can injure the
kidney [8]. Dynamic gadolinium contrast-enhanced MRI can
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measure renal perfusion, but this method is not well validated
and its use is restricted in CKD due to protocols to minimize
the risk of nephrogenic systemic fibrosis [9].
The lack of a gold-standard technique for renal perfusion
means that studies that validate renal ASL against reference tech-
niques must be cautiously interpreted. Renal cortical perfusion
measured by PASL-FAIR was compared with blood flow mea-
sured by ultrasound flowmetry in a single isolated ex vivo swine
kidney, with the greatest observed difference of 13% [10]. Artz
et al. [11] compared renal perfusion acquired with a PASL-FAIR
technique at 1.5T in 11 swines. Both ASL and microspheres
showed an increase in perfusion during an acetylcholine chal-
lenge and a decrease during administration of isoflurane. The
two perfusion techniques showed a good correlation (r¼ 0.81,
P< 0.0001) with a linear relationship in the physiologic range
(microsphere perfusion<550mL/min/100 g), but perfusion val-
ues measured by ASL were systematically lower than those mea-
sured by microspheres. This may have been due in part to
assumptions around the kinetic model used to determine the
ASL perfusion values, but may also reflect the poor reproducibil-
ity and accuracy of the microsphere technique itself.
Ritt et al. [12] measured perfusion by both renal ASL and
para-aminohippurate clearance in 24 patients with metabolic
syndrome and a Cockroft and Gault estimated creatinine
clearance60mL/min. Renal perfusion by the two techniques
correlated modestly (r¼ 0.575, P< 0.001). After the patients
had 2 weeks of therapy with telmisartan, an 11% increase of re-
nal plasma flow by para-aminohippurate clearance was associ-
ated with a 6% increase by PASL-FAIR. Shimizu et al. [13]
described a modest correlation between cortical renal perfusion
by a pCASL technique and 99mTc-MAG3 scintigraphy in 14
healthy volunteers. There is conflicting evidence with respect to
the similarity of perfusion estimates by dynamic gadolinium
contrast-enhanced MRI and ASL [14–16]. This is expected
given the differences in the tracer kinetic properties of magneti-
cally labelled water and gadolinium contrast agents.
REPRODUCIBILITY OF RENAL ASL
Renal perfusion measurements by ASL are influenced by several
patient-specific and technical factors, as discussed in the
Supplementary data. Comparisons of reproducibility measures
are also constrained by the disparate ways in which perfusion
and reproducibility values are presented. Within-subject repro-
ducibility of perfusion by renal ASL in 17 studies is summarized
in Table 1. The range of study participants include healthy vol-
unteers, hypertensives [25], patients with lupus nephritis [29],
and kidney transplant recipients [17, 28]. Overall, cortical perfu-
sion had moderate to good short-term reproducibility in the
same visit [intraclass correlation (ICC) 0.62–0.98; coefficient of
variation (CV) 3–18%] and between different visits (ICC 0.85–
0.97; CV 4–13%). Ensuring reproducibility of medullary perfu-
sion measurements provides additional challenges. These in-
clude reduced contrast:noise ratio due to lower perfusion, renal
medullary volumes prone to errors in accurate segmentation
and signal loss from the longer transit time of the magnetically
labelled bolus as it initially passes through the cortex. Therefore
it is not surprising that medullary perfusion is reported as less
reproducible both within visits (ICC 0.27–0.94; CV 3–43%)
FIGURE 1: Schematic showing basic principles of ASL. (A) Pulsed ASL (PASL) showing a single radiofrequency pulse for labelling followed
by a post-label delay before the image is acquired within one TR (repetition time), with a label-control ASL pair shown. This sequence is
then repeated to collect multiple ASL pairs. (B) Pseudocontinous ASL (pCASL) showing a train of radiofrequency pulses for labelling fol-
lowed by a post-labelling delay. (C) Example control and label images and the resulting perfusion-weighted (PW) image created by subtrac-
tion of the label from the control image.
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and between visits (ICC 0.13–0.96; 4–37%). Studies in which
both intra- and intervisit reproducibility were measured sug-
gest that intervisit reproducibility is greater [17, 22, 26]. At the
time of this review, there are no published studies comparing
the reproducibility of ASL at different magnetic field strengths
or under different labelling approaches. Similarly, we found no
studies of reproducibility between centres.
RENAL ASL IN HEALTHY VOLUNTEERS
This review has highlighted several caveats in terms of both the
ASL acquisition and perfusion quantification methods
(Supplementary data). Supplementary data, Table S1 shows the
range of reported renal cortical perfusion values ranging from
(139–427mL/100 g/min) in healthy volunteers. Authors de-
scribed renal perfusion by ASL under physiological challenges
including water loading [33], intravenous saline [19, 20] and
injections of furosemide [34]. Reduced renal perfusion with age
was found in two recent studies [13, 21].
RENAL ASL IN KIDNEY DISEASE
Renal ASL has been applied in the study of CKD [18, 21, 33,
35–41], AKI [42], lupus nephritis [30, 43], metabolic syndrome
[12], diabetes [39, 44], hypertension [45, 46], heart failure [36]
and renovascular disease [38]. Consistent findings from these
studies are that renal cortical perfusion is reduced in CKD com-
pared with healthy volunteers; renal perfusion reduces with in-
creasing stage of CKD and correlates to eGFR (Table 2).
RENAL ASL IN RENAL TRANSPLANT
RECIPIENTS AND LIVING KIDNEY DONORS
Renal ASL has been applied in kidney transplant studies.
Prominent findings include that renal cortical ASL perfusion
values differ between patients with early and delayed graft func-
tion and correlate with allograft function [29, 47–51]. In a
group of 98 transplant recipients, perfusion by PASL-FAIR re-
duced with increasing stage of CKD [47]. Cutajar et al. [51]
showed that renal ASL can be used to determine filtration frac-
tion and could potentially act as a biomarker of renal functional
reserve in potential living kidney donors.
LONGITUDINAL AND MULTIPARAMETRIC
STUDIES
The non-invasive, short-lived nature of the tracer and rapid ac-
quisition time make renal ASL inherently suited to repeated
studies over a range of timescales. These allow repeated meas-
ures experiments that would not be possible with any other
Table 1. Reproducibility of renal perfusion by ASL
References Participants, n B0 (T) Intravisit Intervisit
ICC CV (%) ICC CV (%) Interval
(days)a
Artz et al. [17] 10 (HV) þ 14 (P) 1.5 0.96–0.98 (C)
0.72–0.78 (M)
4.8–6.0 (C)
16.7–26.7 (M)
0.89–0.94 (C)
0.13–0.63 (M)
7.6–13.1 (C)
19.8–37.0 (M)
746 83 (HV)
196 21 (P)
Chowdhury et al. [18] 12 (HV) 1.5 3.3 (C)
Chowdhury et al. [19] 12 (HV) 1.5 3.3 (C)
Cox et al. [20] 11 (HV) 1.5/3 0.80 (C)
0.61 (W)
9.36 4.4 (C)
14.96 3.8 (W)
NR
Cutajar et al. [21] 5 (HV) 1.5 7.1–7.5 (C)
5.4–5.9 (W)
21 (8–174)a
Cutajar et al. [14] 16 (HV) 1.5 14–18 (W) 7 (7–56)a
Gardener and Francis [22] 4 (HV) 1.5 10–20 (C) NR
Getzin et al. [23] 15 (HV) 1.5 0.77 (C)
0.83 (M)
6.7 (C) 10 (M)
Gillis et al. [24] 12 (HV) 3 0.85 (C)
0.86 (W)
9.2 (C)
7.1 (W)
4–28
Hammon et al. [25] 5 (HV)þ 9 (P) 1.5 0.95–0.96 (C)
0.92–0.94 (M)
0.93–0.97 (W)
3.0–3.86 1.2–1.7 (C)
3.3–3.96 1.8–2.1 (M)
2.3–3.26 1.0–1.5 (W)
0.97 (C)
0.96 (M)
0.97 (W)
4.26 1.3 (C)
4.16 1.4 (M)
3.46 0.9 (W)
14
Karger et al. [26] 3 (HV) 1.5 4.1 (W) 28
Kim et al. [27] 25 (HV) 3 0.90 (C)
0.42 (M)
17.6 (C)
42.9 (M)
Lanzman et al. [28] 3 (P) 1.5 4.1 (C) <35
Rapacchi et al. [29] 10 (HV) þ 10(P) 1.5 0.62–0.66 (C)
0.46–0.47 (M)
10.9–11.6 (C)
20.8–21.1 (M)
Robson et al. [30] 4 (HV 1.5 1.7–8 (W) 7–23 (W) 7
Robson et al. [31] 4 (HV) 1.5 8.8 (W)
Wu et al. [16] 4 (HV) 3 7.9 (C)7.2 (M)
aValues are mean6 SD or median (range).
B0, magnetic ﬁeld strength (Tesla); C, cortex; CV, coefﬁcient of variation; HV, healthy volunteers; M, medulla; NR, not reported; P, patients; W, whole kidney.
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perfusion technique in humans and may provide novel insights
into drug mechanisms and renal pathophysiology. Examples of
longitudinal studies include two randomized double-blinded
crossover studies by Chowdhury et al. [19, 20]. Distinct effects
of commonly used intravenous fluids on renal perfusion were
found by performing ASL six times over 2 h after an infusion of
one intravenous fluid then repeating the experiment on a
second day for a different intravenous fluid. Niles et al. [50]
performed serial ASL imaging in 15 matched pairs of living kid-
ney donors and recipients four times over 2 years. Significant
differences were found in the 2-year profiles of cortical perfu-
sion between the remaining kidney of donors compared with
the transplanted kidney. Furthermore, a potential long-term
protective effect of losartan on perfusion was seen between
transplant recipients. The ability of renal ASL to track the fate
of perfusion in the transplanted and remaining kidney elegantly
demonstrates the potential of the technique. Longitudinal
studies using renal ASL have also been described in the
setting of renin–angiotensin system blockade [12, 24, 46],
hyperglycaemia [44], renal denervation [45] and extracorporeal
lithotripsy [53].
RECOMMENDATIONS AND CONCLUSION
Renal ASL is a powerful tool for non-invasive measurement of
regional renal perfusion in humans, with a typical in plane reso-
lution of 2–3mm. Renal perfusion lacks a gold standard but the
ASL technique has been validated against microspheres in ani-
mals and para-aminohippurate clearance in humans. Renal
ASL yielded reproducible measurements of renal cortical and
medullary perfusion in the studies that have been performed to
date. Reproducibility is poorer in the medulla than the cortex,
as expected. Renal ASL is highly suited to repeated measure-
ments and longitudinal studies demonstrating the potential
prognostic ability of renal ASL are anticipated. The technique
shows great promise as part of multiparametric studies of renal
structure and function that might inform drug development
and be clinically informative. At the time of this review, there
are insufficient data comparing several renal ASL variants to
make definitive recommendations on the best practice for ASL
data acquisition in terms of the optimal ASL labelling scheme,
image readout strategy and motion compensation method.
Furthermore, there is conflicting evidence and no direct com-
parisons to resolve whether background suppression improves
ASL quantification. Multidelay acquisitions to model arterial
transit time cannot be currently universally recommended as
these are more technically challenging; however, they should be
considered where desired. The most historically popular tech-
nique is a pulsed ASL scheme with a single-slice balanced
steady-state free precession readout and motion correction.
However, there are well-supported rationales for more recently
described alternative approaches that suit whole kidney perfu-
sion measurements. There is also variation in how ASL images
are analysed to quantify perfusion values in terms of assump-
tions in the kinetic model and how renal cortex and medulla
regions are defined. The lack of a harmonized approach to im-
age acquisition, analysis and reporting might hinder progress in
the clinical validation and use of the technique. Thus we have
made some recommendations in Table 3. It is important to em-
phasize that in longitudinal studies the precise way in which
ASL is applied is likely to matter less than ensuring consistency
of experimental conditions for repeated measures to maintain
reproducibility. The priority areas in which more studies are ur-
gently needed include animal studies to validate ASL against
reference renal perfusion techniques such as transit time ultra-
sound flowmetry; human longitudinal multiparametric MRI
studies that combine ASL perfusion with other MRI measures
outlined in this issue [53–55]; clinical studies that use measured
rather than eGFR and studies that validate renal perfusion
against a clinical outcome, such as a change in GFR, fibrosis or
graft survival. In conclusion, renal ASL is almost ready for clini-
cal use. Collaborative projects such as the COST action
PARENCHIMA will accelerate clinical validation of renal ASL
as part of a multiparametric assessment of renal perfusion, oxy-
genation, oedema and fibrosis.
SUPPLEMENTARY DATA
Supplementary data are available at ndt online.
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Table 3. Minimum recommendations for reporting renal ASL studies
Outline patient preparation (e.g. hydration)
Outline subject characteristics
Measure systemic haemodynamics ( e.g. blood pressure)
Report current medications (especially those targeting the renin–
angio-tensin system)
Outline the labelling scheme
Report the duration of the post-label delay
Outline the readout scheme
Explicitly outline how motion compensation was handled
Explicitly state whether background suppression was applied
Acquire a T1 map to use in the kinetic model
Describe how the region of interest for ASL analysis is selected
Report cortical and medullary values separately
Report within-subject reproducibility for your site preferably both
within and between visits
Measure other renal MRI parameters if possible (e.g. BOLD, diffusion)
Table 2. Signiﬁcant correlations of renal perfusion by ASL with eGFR
Reference Setting eGFR method r-value
Breidthardt-2015 [35] CKD MDRD 0.52
Gillis-2016 [36] CKD CKD-EPI 0.73
Li-2017 [32] CKD CKD-EPI 0.67
Mora-Gutierrez-2017 [38] CKD MDRD 0.62
Artz-2011-MRI [48] Healthy
volunteer/Transplant
MDRD 0.85/
0.62
Heusch-2014 [46] Transplant MDRD 0.59
Hueper-2015 [47] Transplant MDRD 0.64
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